Thomas DiRaimondo
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: 5 M $ as of 29/04/2024
Profile
Thomas DiRaimondo is the founder of Sitari Pharma, Inc. (founded in 2013).
He is currently working as the Chief Scientific Officer at Janux Therapeutics, Inc. since 2018.
Dr. DiRaimondo has a doctorate degree from Stanford University and undergraduate and graduate degrees from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC.
0.20% | 01/01/2024 | 101,532 ( 0.20% ) | 5 M $ | 29/04/2024 |
Thomas DiRaimondo active positions
| Companies | Position | Start |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/04/2018 |
Former positions of Thomas DiRaimondo
| Companies | Position | End |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Founder | 31/07/2019 |
Training of Thomas DiRaimondo
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas DiRaimondo
